Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market
Holding TNGX?
Track your performance easily

Tango Therapeutics (TNGX) Financial Statements

292 Followers

Tango Therapeutics Financial Overview

Tango Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.132; its P/E ratio is -7.33; Tango Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 19.88M$ 6.47M$ 5.43M$ 10.73M$ 9.60M
Gross Profit$ 19.88M$ 6.47M$ 5.43M$ 10.73M$ 14.60M
EBIT$ -27.56M$ -40.51M$ -35.01M$ -24.11M$ -22.10M
EBITDA$ -25.93M$ -38.99M$ -34.40M$ -21.86M$ -22.36M
Net Income Common Stockholders$ -25.63M$ -37.91M$ -30.76M$ -21.43M$ -20.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 322.11M$ 343.60M$ 336.88M$ 359.88M$ 311.51M
Total Assets$ 381.45M$ 406.22M$ 402.57M$ 428.19M$ 379.33M
Total Debt$ 37.84M$ 38.23M$ 38.92M$ 39.51M$ 39.89M
Net Debt$ -284.27M$ -305.36M$ -297.96M$ -320.37M$ -271.62M
Total Liabilities$ 133.78M$ 141.77M$ 149.46M$ 151.59M$ 166.38M
Stockholders Equity$ 247.67M$ 264.45M$ 253.11M$ 276.60M$ 212.94M
Cash Flow-
Free Cash Flow$ -23.93M$ -38.05M$ -27.69M$ -31.15M$ -25.14M
Operating Cash Flow$ -23.61M$ -37.86M$ -27.47M$ -31.14M$ -24.48M
Investing Cash Flow$ 12.70M$ -11.20M$ 33.85M$ -56.66M$ 32.69M
Financing Cash Flow$ 1.31M$ 42.98M$ 1.47M$ 80.28M$ 586.00K
Currency in USD

Tango Therapeutics Earnings and Revenue History

Tango Therapeutics Debt to Assets

Tango Therapeutics Cash Flow

Tango Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis